Grade I Meningioma
Associated Genetic Biomarkers
NCI Definition: A benign meningioma which may recur in approximately 7-20% of the cases. This category includes the angiomatous meningioma, fibrous meningioma, lymphoplasmacyte-rich meningioma, meningothelial meningioma, metaplastic meningioma, microcystic meningioma, psammomatous meningioma, secretory meningioma, and transitional meningioma. 
There is 1 clinical trial for grade I meningioma, of which 1 is open and 0 are completed or closed. Of the trial that contains grade I meningioma as an inclusion criterion, 1 is phase 2 (1 open).
SSTR2 is the most frequent gene inclusion criterion for grade I meningioma clinical trials .
Lutetium lu 177 dotatate is the most common intervention in grade I meningioma clinical trials.
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.